Ads
related to: moderna vaccine
Search results
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 6 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 6 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 20 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 6 days agoThe FDA has informed Moderna that it is working to conclude...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 7 days agoOther nations' regulatory bodies followed suit. The rest, as they say, is history. Pandemic-prompted...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 12 hours agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Is This a Setback for Moderna?
The Motley Fool via AOL· 2 days agoSo, this isn't a setback for Moderna, and investors can breathe a sigh of relief. But it's still important to keep a close eye on the situation for one...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 6 days agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...
